Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
04/12/2000 | EP0992243A1 Prophylactic/remedial agent |
04/12/2000 | EP0991946A1 Diagnostic assays using soluble endothelial cell protein c/activated protein c receptor |
04/12/2000 | EP0991775A1 Method to identify pesticidal microbes |
04/12/2000 | EP0991774A1 Method for increasing secretion of proteins in eukaryotic host cells |
04/12/2000 | EP0991770A2 Prostate cancer gene |
04/12/2000 | EP0991769A2 A method for plant protection against insects or nematodes |
04/12/2000 | EP0991768A1 Sucrose-binding proteins |
04/12/2000 | EP0991762A2 SURFACE PROTEIN (SPsA PROTEIN) OF STREPTOCOCCUS PNEUMONIAE, DELETED DERIVATIVES, EXPRESSION SYSTEM FOR SAID PROTEINS AND VACCINE SYSTEM WITH SAID PROTEINS |
04/12/2000 | EP0991761A1 Novel mutants of gram negative mucosal bacteria and application thereof in vaccines |
04/12/2000 | EP0991760A1 Tumor growth inhibition- and apoptosis-associated genes and polypeptides and methods of use thereof |
04/12/2000 | EP0991759A1 Ntn-2 member of tnf ligand family |
04/12/2000 | EP0991758A1 Smad6 and uses thereof |
04/12/2000 | EP0991757A1 Novel tumor antigens |
04/12/2000 | EP0991756A2 Agents for the pre-symptomatic detection, prevention and treatment of breast cancer in humans |
04/12/2000 | EP0991666A1 Alpha 1-antitrypsin preparation and method for the production thereof |
04/12/2000 | EP0991665A1 Peptides and compounds that bind to the il-5 receptor |
04/12/2000 | EP0991664A1 Novel pharmaceutically active compounds interacting with gtp-binding proteins |
04/12/2000 | EP0991663A1 $i(MYCOBACTERIUM) STRAIN WITH MODIFIED $i(ERP) GENE AND VACCINE COMPOSITION CONTAINING SAME |
04/12/2000 | EP0991662A1 Chlamyidia trachomatis specific peptides and their use in diagnostic assays |
04/12/2000 | EP0991661A2 Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof |
04/12/2000 | EP0991659A1 Peptides and compounds that bind to the il-5 receptor |
04/12/2000 | EP0991421A2 Detection and modulation of the iaps and naip for the diagnosis and treatment of proliferative disease |
04/12/2000 | EP0991420A1 Modulation of the hypothalamic-pituitary-adrenal-adipose axis with leptin receptor ligands |
04/12/2000 | EP0991385A2 Autoimmune inner ear disease antigen and diagnostic assay |
04/12/2000 | EP0991319A2 Treatment for diabetes |
04/12/2000 | EP0950061A4 Heat shock protein complexes |
04/12/2000 | EP0814838A4 Antigen presenting system and methods for activation of t-cells |
04/12/2000 | EP0809654B1 Calcitonin salmon analogues, their preparation, medicinal use and use as analytical agents |
04/12/2000 | EP0766825A4 Preparation of derivatized 10,10'-substituted-9,9'-biacridine luminescent molecules and signal solutions |
04/12/2000 | EP0676052B1 Detection of cystic fibrosis or a cftr gene mutation |
04/12/2000 | EP0642666B1 Hepatitis c assay |
04/12/2000 | EP0452413B1 Generation and selection of novel dna-binding proteins and polypeptides |
04/12/2000 | EP0362218B2 IMPROVED METHOD FOR PRODUCING FACTOR VIII:c-TYPE PROTEINS |
04/12/2000 | CN1250479A Modulators of the function of receptors of the TNF/NGF receptor family |
04/12/2000 | CN1250478A A gene homologous to fox sperm acrosomal protein FSA-1 (CBCALD05) |
04/12/2000 | CN1250381A Remedies for lymphocytic tumors |
04/12/2000 | CN1250098A Human P47 coding series and the polypeptide therewith and its preparation |
04/12/2000 | CN1250097A New human gene coding series and the polypeptide therewith and its preparation |
04/12/2000 | CN1250096A New human protein phosphatase subunit and its coding series and preparation |
04/12/2000 | CN1250095A New human gene series and the polypeptide therewith and its preparation |
04/12/2000 | CN1250094A New human kernon acceptor co-repressor coding series and the polypeptide therewith and its preparation |
04/12/2000 | CN1250055A Production of recombination human lactoferritin |
04/12/2000 | CN1051317C Displacement chromatography process and purified hemoglobin product |
04/11/2000 | US6048971 Recombinant human erythropoietin mutants |
04/11/2000 | US6048970 Prostate growth-associated membrane proteins |
04/11/2000 | US6048967 Blood compound associated with a nitroxide compound to prevent or alleviate the side effects of oxygen stress |
04/11/2000 | US6048966 Preventing blood loss using fibrinogenas a seal; incubation of fibrinogen with splitting enzyme with subseqent application of digested peptides to desired site of action |
04/11/2000 | US6048965 Polypeptide that controls the premature degradation of transcripts |
04/11/2000 | US6048963 Polynucleotides and polypeptides associated with benign prostatic hypertrophy |
04/11/2000 | US6048962 Mammalian protein allergen; for the diagnosis and treatment of mammalian allergic response |
04/11/2000 | US6048898 Synthesis of glatiramer acetate (copolymer-1) |
04/11/2000 | US6048840 Hypoglycaemic peptides |
04/11/2000 | US6048839 Materials and methods for controlling insect pests with pesticidal proteins obtainable from Bacillus thuringiensis isolates PS158C2 and HD511 |
04/11/2000 | US6048838 Insecticidal protein toxins from xenorhabdus |
04/11/2000 | US6048837 Dietetics |
04/11/2000 | US6048729 Animal transfected clonal cells for the expression of therapeutic products |
04/11/2000 | US6048724 Producing mammalian transfected cell strain which expresses exogenous dna encoding erythropoietin and glucagons; for prevention or treatment of a condition in which insulin production or glucagon function is defective |
04/11/2000 | US6048720 Conjugates of a polypeptide and a biocompatible polymer |
04/11/2000 | US6048718 Mitochondrial polypeptide; for the treatment of cancer and nervous system disorders; anticarcinogenic agents |
04/11/2000 | US6048717 Enzyme inhibitor that prevents cleavage by immunoglobulin; for treatment of asthma and autoimmune disease |
04/11/2000 | US6048716 Microorganism polypeptide; for infection prevention bactericides; wound healing agents |
04/11/2000 | US6048715 Two-phase partition affinity separation system and affinity separated cell-containing composition |
04/11/2000 | US6048711 Human G-protein coupled receptor polynucleotides |
04/11/2000 | US6048710 Vector comprising nucleic acid coding a kinase; for the production and secretion of proteins in cells |
04/11/2000 | US6048709 Polynucleotide sequence coding a endothelial marker polypeptide; for the detection and therapy of heart and vascular disorders |
04/11/2000 | US6048705 Sandwich immunoassays for collagen type I degradation products |
04/11/2000 | US6048704 Microfibrillar protein purified from human tissue which binds vein tissue antibody; for treatment and diagnosis of human vein tissue blockage disease |
04/11/2000 | US6048702 Antibody which specifically binds to a oncogene modulating peptide; for the diagnosis and treatment of breast, prostate, or liver cancer; anticarcinogenic agents; antitumor agents |
04/11/2000 | US6048700 Detecting the presence of a bordetella antigen in a sample; contacting an antibody specific antigen with said sample and detecting binding of an antibody to bordetta antigen, binding of the antbody is an indicator of presence of antigen |
04/11/2000 | US6048685 In vitro diagnostic assay employing HIV-2 antigens for the detection of HIV-2 specific antibodies |
04/11/2000 | US6048539 Immunology |
04/11/2000 | US6048538 Peptides derived from the non-structural proteins of foot and mouth disease virus as diagnostic reagents |
04/11/2000 | US6048530 Inducing cytotoxic t-cell response against viruses, bacteria, fungi, and parasites; immunology |
04/11/2000 | US6048529 PVA or PEG conjugates of peptides for epitope-specific immunosuppression |
04/11/2000 | US6048527 Non-autoreactive; n-propionylated neisseria serogroup b capsular polysaccharide-protein conjugates |
04/11/2000 | US6048526 Monoclonal antibodies reactive with defined regions of the T cell antigen receptor |
04/11/2000 | US6048524 In vivo production and delivery of erythropoietin for gene therapy |
04/11/2000 | CA2220729C Method for refolding insoluble aggregates of hepatitis c virus protease |
04/11/2000 | CA2016663C Enzyme inhibiting peptide derivatives |
04/11/2000 | CA2016656C Enzyme inhibitors |
04/11/2000 | CA2009946C Pasteurized, purified von willebrand factor concentrate and a process for the preparation thereof |
04/11/2000 | CA2009579C Insulin analogs |
04/11/2000 | CA1340958C Synthetic peptides representing a t-cell epitope as a carrier molecule for conjugate vaccines |
04/11/2000 | CA1340956C Synthetic peptides representing a t-cell epitope as a carrier molecule for conjugate vaccines |
04/09/2000 | CA2639757A1 Amino acid modified polypeptides |
04/09/2000 | CA2639637A1 Amino acid modified polypeptides |
04/09/2000 | CA2639620A1 Amino acid modified polypeptides |
04/06/2000 | WO2000018959A1 Trex, a novel gene of traf-interacting ext gene family and diagnostic and therapeutic uses thereof |
04/06/2000 | WO2000018954A2 Use of pex in the treatment of metabolic bone diseases |
04/06/2000 | WO2000018952A1 Use of s-ydcb and b-ydcb, essential bacterial genes |
04/06/2000 | WO2000018940A1 Plants and plants cells encoding the wild type cop1 gene and the coil domain thereof |
04/06/2000 | WO2000018933A1 Immunotherapy of cancer through expression of truncated tumor or tumor-associated antigen |
04/06/2000 | WO2000018932A2 Receptor based antagonists and methods of making and using |
04/06/2000 | WO2000018929A2 Paramyxovirus vaccines |
04/06/2000 | WO2000018928A1 Treatment of wilt diseases |
04/06/2000 | WO2000018926A1 USE OF BIFUNCTIONAL α-AMYLASE SUBTILISIN INHIBITOR PROMOTER SEQUENCE OF BARLEY TO CONFER EXPRESSION IN SEEDS |
04/06/2000 | WO2000018925A1 Gene expressed in prostate cancer |
04/06/2000 | WO2000018924A1 Human small proline-rich molecule |
04/06/2000 | WO2000018923A2 Slgp protein and nucleic acid molecule and uses therefor |
04/06/2000 | WO2000018922A2 Human carbohydrate-associated proteins |